287
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival

, , , , , , , , , , , & ORCID Icon show all
Pages 794-801 | Received 18 Dec 2019, Accepted 06 May 2020, Published online: 01 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kenji Morimoto, Junji Uchino, Takashi Yokoi, Takashi Kijima, Yasuhiro Goto, Akira Nakao, Makoto Hibino, Takayuki Takeda, Hiroyuki Yamaguchi, Chieko Takumi, Masafumi Takeshita, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada & Koichi Takayama. (2021) Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study. OncoImmunology 10:1.
Read now

Articles from other publishers (6)

Oscar Arrieta, Daniela Cárdenas-Fernández, Oscar Rodriguez-Mayoral, Salvador Gutierrez-Torres, Diana Castañares, Diana Flores-Estrada, Edgar Reyes, Dennis López, Pablo Barragán, Pamela Soberanis Pina, Andres F. Cardona & Jenny G. Turcott. (2024) Mirtazapine as Appetite Stimulant in Patients With Non–Small Cell Lung Cancer and Anorexia. JAMA Oncology 10:3, pages 305.
Crossref
Clelia Madeddu, Silvia Busquets, Clelia Donisi, Eleonora Lai, Andrea Pretta, Francisco Javier López-Soriano, Josep Maria Argilés, Mario Scartozzi & Antonio Macciò. (2023) Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer. Cancers 15:4, pages 1076.
Crossref
Maurizio Muscaritoli, Gil Bar-Sela, Nicolo Matteo Luca Battisti, Borislav Belev, Jorge Contreras-Martínez, Enrico Cortesi, Ione de Brito-Ashurst, Carla M. Prado, Paula Ravasco & Suayib Yalcin. (2023) Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO). Cancers 15:2, pages 380.
Crossref
Madeline MacDonald, Darin Poei, Alexis Leyba, Raymond Diep, Krithika Chennapan, Christopher Leon, Bing Xia, Jorge J. Nieva & Robert Hsu. (2023) Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. Cancer Treatment and Research Communications 36, pages 100752.
Crossref
Yizhen Guo, Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li, Tyler Haddad, Andrew Johns, Latha P. Ganesan, Yiping Yang, Daniel J. Spakowicz, Peter G. Shields, Kai He, Erin M. Bertino, Gregory A. Otterson, David P. Carbone, Carolyn Presley, Samuel K. Kulp, Thomas A. Mace, Christopher C. Coss, Mitch A. Phelps & Dwight H. Owen. (2022) Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy. Clinical Lung Cancer 23:4, pages 345-355.
Crossref
Oscar Arrieta, Andrés F. Cardona, Luis Lara-Mejía, David Heredia, Feliciano Barrón, Zyanya Lucia Zatarain-Barrón, Francisco Lozano, Vladmir Cordeiro de Lima, Federico Maldonado, Francisco Corona-Cruz, Maritza Ramos, Luis Cabrera, Claudio Martin, Luis Corrales, Mauricio Cuello, Marisol Arroyo-Hernández, Enrique Aman, Ludwing Bacon, Renata Baez, Sergio Benitez, Antonio Botero, Mauricio Burotto, Christian Caglevic, Gustavo Ferraris, Helano Freitas, Diego Lucas Kaen, Sebastián Lamot, Gustavo Lyons, Luis Mas, Andrea Mata, Clarissa Mathias, Alvaro Muñoz, Ana Karina Patane, George Oblitas, Luis Pino, Luis E. Raez, Jordi Remon, Leonardo Rojas, Christian Rolfo, Alejandro Ruiz-Patiño, Suraj Samtani, Lucia Viola, Santiago Viteri & Rafael Rosell. (2020) Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group. Critical Reviews in Oncology/Hematology 153, pages 103033.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.